share_log

The Latest Analyst Ratings For Insulet

The Latest Analyst Ratings For Insulet

銀休特的最新分析師評級
Benzinga ·  08/12 16:00  · 評級/大行評級
5 analysts have shared their evaluations of Insulet (NASDAQ:PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三個月中,5位分析師分享了對銀休特(NASDAQ: PODD)的評估,表達了看好和看淡的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級,展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $232.4, a high estimate of $250.00, and a low estimate of $220.00. This current average has increased by 1.6% from the previous average price target of $228.75.
分析師分析的12個月價格目標提供了有關信息,平均目標爲232.4美元,最高估值爲250.00美元,最低估值爲220.00美元。與先前的平均目標價228.75美元相比,當前平均目標價已上漲1.6%。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析:詳細分析
The perception of Insulet by financial experts is analyzed through...
通過最近的分析師行動...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論